Prosight Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001617201

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 32 positions · Total reported value $515.48M · Top-10 concentration 70.6% · Updated 2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.6% · 9 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.1% · vs SPY -3.2% · Prev Value $580.35M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -6.1% · vs SPY -8.3% · Latest Value $515.48M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Prosight Management, LP disclosed 32 equity positions with a combined reported value of $515.48M. The filing implies a focused portfolio: its ten largest positions account for 70.6% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were LKFT ($59.25M), STTK ($52.16M), JANX ($50.86M). By sector, the heaviest allocations are Health Care 85.9%, Consumer Discretionary 2.0%. Versus the prior quarter, allocation shifted toward Health Care (+2.4pp), Consumer Discretionary (+2.0pp) and away from Other (-1.7pp), Technology (-3.2pp).

Versus the prior quarter, Prosight Management, LP opened 9 new positions, trimmed 12 and fully exited 13, a turnover rate of 75.6% of positions. The portfolio's overlap with the prior quarter was 51% of names.

The largest new positions opened in Q3 2026 were PRVA ($20.67M), DNLI ($11.38M), PRAX ($10.60M).

Of the 13 positions fully exited versus the prior quarter, the largest were VEEV ($18.85M), CRNX ($14.02M), ICUI ($7.48M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • PRVA PRIVIA HEALTH GROUP INC · $20.67M
  • DNLI DENALI THERAPEUTICS INC · $11.38M
  • PRAX PRAXIS PRECISION MEDICINES I · $10.60M
  • HQY HEALTHEQUITY INC · $10.24M
  • BBIO BRIDGEBIO PHARMA INC · $9.87M
  • HUM HUMANA INC · $8.39M
  • ENOV ENOVIS CORPORATION · $4.89M
  • QTRX QUANTERIX CORP · $3.06M

Fully Exited (vs previous quarter)

  • VEEV VEEVA SYS INC · prev qtr: $18.85M
  • CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $14.02M
  • ICUI ICU MED INC · prev qtr: $7.48M
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $6.76M
  • PRCT PROCEPT BIOROBOTICS CORP · prev qtr: $6.06M
  • WGS GENEDX HOLDINGS CORP · prev qtr: $5.87M
  • OPCH OPTION CARE HEALTH INC · prev qtr: $5.68M
  • EBS EMERGENT BIOSOLUTIONS INC · prev qtr: $3.85M

Insider Transactions (Form 4)

Latest Prosight Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Prosight Management, LP is an SEC-registered 13F filer based in Dallas, TX, United States. As of Q2 2026 it reported 36 US equity positions with a combined value of $580.35M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: DALLAS, TX, United States
  • SEC registration: 801-108047 (status: Approved), registered 2016-07-01
  • Regulatory AUM (Form ADV): $1.04B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: prosightcapital.com

Portfolio Structure

  • 36 positions · $580.35M reported value (Q2 2026)
  • Top 10 holdings = 70.7% of reported value
  • Largest position: LKFT (LAKEFRONT BIOTHERAPEUTICS NV) at 10.6%
  • Average position size: $16.12M

Sector Tilt

  • Health Care 83.6%
  • Information Technology 3.2%
  • (classified holdings cover 87% of value)

Quarterly Activity

  • Q2 2026: 5 new, 16 added, 15 reduced, 15 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively rotating into high-growth biotech/healthcare names (e.g., STTK, ABVX) while reducing exposure to established but underperforming positions (e.g., BSX, INSM), signaling a bullish stance on innovative therapeutics and a bearish view on legacy healthcare stocks. 2. Key moves: - Added: STTK (+28.4% shares), ABVX (+250.9% shares), IRTC (+21.4% shares), ALKS (+39.5% shares), and PRVA (new position). - Reduced: LKFT (-2.2% shares), JANX (-22.6% shares), NKTR (-3.1% shares), INSM (-36.6% shares), and BSX (-56.7% shares). 3. Portfolio structure: Highly active, concentrated in Health Care (90%+ of top 10), with aggressive risk appetite (e.g., ABVX’s 250% share increase). No passive holdings detected. 4. Per-holding one-liner: - LKFT: LAKEFRONT BIOTHERAPEUTICS NV (biopharma, unverified). - STTK: SHATTUCK LABS INC (immunotherapy, unverified). - JANX: JANUX THERAPEUTICS INC (oncology, unverified). - NKTR: NEKTAR THERAPEUTICS (drug delivery, unverified). - ABVX: ABIVAX SA (virology/immunology, unverified). - INSM: INSMED INC (infectious diseases, unverified). - BSX: BOSTON SCIENTIFIC CORP (medical devices). - IRTC: IRHYTHM HOLDINGS INC (heart rhythm monitoring). - ALKS: ALKERMES PLC (CNS/psychiatry drugs). - PRVA: PRIVIA HEALTH GROUP INC (primary care services). 5. Style summary: Aggressive biotech/healthcare rotation favoring high-growth innovators over established names.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-16 17:34

Sector Allocation

Health Care 85.9%
Other 11.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.00M $59.25M 11.49%
11.49%
Reduce
2 7.65M $52.16M 10.12%
10.12%
Add
3 2.94M $50.86M 9.87%
9.87%
Reduce
4 785.00K $47.53M 9.22%
9.22%
Reduce
5 376.79K $37.31M 7.24%
7.24%
Add
6 238.09K $27.18M 5.27%
5.27%
Reduce
7 550.00K $24.01M 4.66%
4.66%
Reduce
8 200.98K $22.84M 4.43%
4.43%
Add
9 550.00K $22.29M 4.32%
4.32%
Add
10 1.05M $20.67M 4.01%
4.01%
New
11 800.00K $20.10M 3.90%
3.90%
Add
12 721.10K $19.10M 3.71%
3.71%
Add
13 812.58K $15.28M 2.96%
2.96%
Reduce
14 1.27M $13.66M 2.65%
2.65%
Reduce
15 550.70K $11.38M 2.21%
2.21%
New
16 36.40K $10.60M 2.06%
2.06%
New
17 115.80K $10.24M 1.99%
1.99%
New
18 150.00K $9.87M 1.92%
1.92%
New
19 37.00K $9.13M 1.77%
1.77%
Reduce
20 22.00K $8.39M 1.63%
1.63%
New
21 267.43K $4.89M 0.95%
0.95%
New
22 1.33M $3.61M 0.70%
0.70%
Add
23 825.00K $3.06M 0.59%
0.59%
New
24 144.76K $2.17M 0.42%
0.42%
New
25 350.88K $1.87M 0.36%
0.36%
Reduce
26 1.60M $1.73M 0.34%
0.34%
Add
27 595.02K $1.56M 0.30%
0.30%
Reduce
28 1.66M $1.33M 0.26%
0.26%
Add
29 229.60K $1.15M 0.22%
0.22%
Add
30 168.38K $1.15M 0.22%
0.22%
Reduce
31 150.00K $614.25K 0.12%
0.12%
Add
32 399.90K $487.88K 0.10%
0.10%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 70% R 70% F1 70% (modelled on 2026-Q2; 7/10 hit)

Low-confidence forecast This fund replaces about 29% of its Top-10 each quarter and backtests at F1 71% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 71% · recall 71% · F1 71% · avg rank error 2.7 · Top-10 turnover 29%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 60% 60% 60% LKFT · MGTX · STTK · MDT · BCRX · KURA · ADCT · QDEL · PRTA · ABCL STTK · ADCT · LKFT · MGTX · KURA · ROIV · BBIO · CYTK · MDT · KIDS
2024-Q2 80% 80% 80% STTK · ADCT · LKFT · MGTX · ROIV · KURA · BBIO · CYTK · MDT · KIDS LKFT · ADCT · ROIV · BBIO · ZBH · MGTX · STTK · KURA · CYTK · SNDX
2024-Q3 70% 70% 70% LKFT · ADCT · BBIO · ROIV · ZBH · STTK · MGTX · KURA · CYTK · KELYA ADCT · LKFT · BBIO · ABCL · MGTX · ROIV · MIRM · ZBH · MCK · KURA
2024-Q4 70% 70% 70% ADCT · LKFT · BBIO · ABCL · MGTX · ZBH · ROIV · MIRM · MCK · SDGR LKFT · ACHC · BBIO · MGTX · ABCL · ADCT · MIRM · ICLR · ROIV · JANX
2025-Q1 70% 70% 70% ACHC · BBIO · LKFT · MGTX · ABCL · JANX · MIRM · ADCT · ICLR · ROIV LKFT · MGTX · BBIO · JANX · ROIV · MIRM · KURA · ADCT · ZYME · FOLD
2025-Q2 90% 90% 90% LKFT · MGTX · JANX · BBIO · ROIV · KURA · MIRM · ADCT · FOLD · ZYME LKFT · UNH · MGTX · ADCT · BBIO · ROIV · FOLD · JANX · KURA · ZYME
2025-Q3 70% 70% 70% LKFT · UNH · MGTX · ADCT · FOLD · JANX · ROIV · KURA · BBIO · ZYME LKFT · MGTX · ADCT · KURA · ISRG · JANX · ROIV · ICLR · SNDX · BBIO
2025-Q4 60% 60% 60% LKFT · MGTX · ADCT · KURA · ISRG · JANX · ICLR · ROIV · SNDX · FOLD PRCT · LKFT · JANX · ADCT · KURA · MGTX · NKTR · VEEV · ICLR · BSX
2026-Q1 70% 70% 70% PRCT · JANX · LKFT · ADCT · KURA · MGTX · NKTR · BSX · ICLR · VEEV NKTR · BSX · JANX · PRCT · LKFT · WGS · STTK · ADCT · KURA · ALNY
2026-Q2 70% 70% 70% NKTR · BSX · JANX · PRCT · LKFT · WGS · STTK · ADCT · ALNY · KURA LKFT · JANX · NKTR · BSX · STTK · INSM · ALNY · SNDX · KURA · ALKS
2026-Q3 ★ 70% 70% 70% LKFT · JANX · BSX · NKTR · STTK · INSM · ALNY · SNDX · IRTC · KURA LKFT · STTK · JANX · NKTR · ABVX · INSM · BSX · IRTC · ALKS · PRVA

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-13. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-13 Trading days32 Holdings7 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-13, and will update as prices arrive.

Portfolio return+1.33%Buy & hold
QQQ synthetic benchmark-13.72%Liquidity weighted
Excess return+15.05%vs benchmark
Barra annualised vol33.9%Model estimate
Realised vol25.9%Annualised in window
Weighted beta0.62Raw exposure
Factor / specific risk52% / 48%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2311-13Prosight Management, LPQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)+1.33%Disclosed long book
QQQ synthetic benchmark-13.72%Liquidity-weighted constituents
Model universe, equal weight+0.30%Opportunity-cost reference
Excess return+15.05%Portfolio − benchmark
Arithmetic return sum+1.73%Difference vs compounded is the cross term
Weighted raw beta0.62Weighted holding betas
Realised volatility (annualised)25.86%Daily returns in window
Barra model volatility (annualised)33.90%Factor + specific
Factor share of variance52.0%Barra factors
Specific share of variance48.0%Stock residuals
Reported value$92.1M13F long US equity

2. Return attribution

The +1.73% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -1.36% -78.7%
Momentum & Growth 3 +1.00% 58.0%
Volatility & Tail Risk 7 +6.39% 369.1%
Industry 12 +8.12% 469.1%
Specific 1 -12.42% -717.5%
Return attribution (style + industry, %)-12.0-6.0+0.0+6.0+12.0Short-term Reversal+0.38Non-linear Size+0.40Leverage (Downside Vol)-0.44Growth-0.74Size+1.07Beta-1.23Momentum+1.37Skewness-1.58Turnover-2.16Max Drawdown+2.82Residual Volatility+3.96Health Care+8.12Historical Volatility-8.24Kurtosis+11.10
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +1.59 +6.97% +11.10% 641.1%
Health Care Industry +1.00 +8.12% +8.12% 469.1%
Residual Volatility Style +1.49 +2.66% +3.96% 228.7%
Max Drawdown Style -1.44 -1.96% +2.82% 162.8%
Momentum Style -0.41 -3.34% +1.37% 79.0%
Size Style -0.59 -1.83% +1.07% 62.0%
Non-linear Size Style +0.44 +0.91% +0.40% 23.1%
Short-term Reversal Style +0.48 +0.79% +0.38% 21.9%
Liquidity Style -0.65 +0.22% -0.14% -8.0%
Mid Cap Style +0.12 -1.69% -0.20% -11.4%
Amihud Illiquidity Style +0.84 -0.40% -0.34% -19.7%
Leverage (Downside Vol) Style +0.24 -1.82% -0.44% -25.2%
Growth Style -0.47 +1.57% -0.74% -42.9%
Beta Style -0.25 +4.85% -1.23% -71.0%
Skewness Style +0.38 -4.21% -1.58% -91.5%
Turnover Style +0.45 -4.77% -2.16% -124.7%
Historical Volatility Style +0.64 -12.86% -8.24% -475.8%
Specific Specific — — -12.42% -717.5%

3. Risk attribution

Annualised volatility is 33.90%; factor risk explains 52.0% of variance and specific risk 48.0%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-51.8-25.9+0.0+25.9+51.8Residual Volatility-4.97Short-term Reversal-1.93Non-linear Size+0.46Kurtosis+0.76Size+1.13Amihud Illiquidity+1.18Beta+1.80Skewness+2.11Liquidity+2.33Growth+3.53Historical Volatility+4.87Max Drawdown+17.23Health Care+23.27Specific+48.00
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 48.0% +16.27% 16.3%
Health Care Industry +1.00 23.3% +7.89% 7.9%
Max Drawdown Style -1.44 17.2% +5.84% 5.8%
Historical Volatility Style +0.64 4.9% +1.65% 1.6%
Growth Style -0.47 3.5% +1.20% 1.2%
Liquidity Style -0.65 2.3% +0.79% 0.8%
Skewness Style +0.38 2.1% +0.72% 0.7%
Beta Style -0.25 1.8% +0.61% 0.6%
Amihud Illiquidity Style +0.84 1.2% +0.40% 0.4%
Size Style -0.59 1.1% +0.38% 0.4%
Kurtosis Style +1.59 0.8% +0.26% 0.3%
Non-linear Size Style +0.44 0.5% +0.16% 0.2%
Leverage (Downside Vol) Style +0.24 0.4% +0.13% 0.1%
Momentum Style -0.41 -0.2% -0.07% -0.1%
Short-term Reversal Style +0.48 -1.9% -0.65% -0.7%
Residual Volatility Style +1.49 -5.0% -1.68% -1.7%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.8-0.70.31.42.5Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.59 +2.10 -2.69
Non-linear Size +0.44 +1.68 -1.24
Mid Cap +0.12 +0.13 -0.01
Beta -0.25 +1.29 -1.55
Momentum -0.41 +0.72 -1.13
Short-term Reversal +0.48 -0.64 +1.12
Residual Volatility +1.49 -0.40 +1.89
Historical Volatility +0.64 +0.86 -0.22
Liquidity -0.65 +0.11 -0.76
Amihud Illiquidity +0.84 +1.16 -0.31
Turnover +0.45 +0.21 +0.25
Growth -0.47 +0.58 -1.06
Leverage (Downside Vol) +0.24 +0.14 +0.10
Skewness +0.38 +0.24 +0.14
Kurtosis +1.59 +0.21 +1.38
Max Drawdown -1.44 -0.08 -1.36

5. Industry allocation & Brinson

Industry allocation (weight, %)-10.020.050.080.0110.0Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -19.18% +4.32% +14.12% -14.12% +14.12%
Health Care 100.0% 1.7% +1.00% +9.16% +22.08% -0.14% -8.02% +0.84%
Communication Services 0.0% 2.6% +0.00% -15.54% +0.06% +0.41% -0.41% +0.41%
Utilities 0.0% 0.8% +0.00% +11.58% -0.20% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.58% -0.24% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +5.56% -1.66% -0.49% +0.49% -0.49%
Industrials 0.0% 11.1% +0.00% +7.16% -2.27% -0.80% +0.80% -0.80%
Total +21.99% +12.84% -21.01% +13.82%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
INSM INSMED INC Health Care 29.49% +6.15% +1.81% Reduce
BSX BOSTON SCIENTIFIC CORP Health Care 26.06% +1.58% +0.41% Reduce
DNLI DENALI THERAPEUTICS INC Health Care 12.35% -9.34% -1.15% New
BBIO BRIDGEBIO PHARMA INC Health Care 10.71% +19.00% +2.04% New
ALNY ALNYLAM PHARMACEUTICALS INC Health Care 9.91% -33.11% -3.28% Reduce
HUM HUMANA INC Health Care 9.11% +17.93% +1.63% New
GENB GENERATE BIOMEDICINES INC Health Care 2.36% -19.64% -0.46% New
Contribution rank Symbol Sector Weight Return Contribution
1 BBIO Health Care 10.71% +19.00% +2.04%
2 INSM Health Care 29.49% +6.15% +1.81%
3 HUM Health Care 9.11% +17.93% +1.63%
4 BSX Health Care 26.06% +1.58% +0.41%
5 GENB Health Care 2.36% -19.64% -0.46%
6 DNLI Health Care 12.35% -9.34% -1.15%
7 ALNY Health Care 9.91% -33.11% -3.28%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-13 (32 trading days), the reported portfolio returned +1.33%, versus -13.72% for the QQQ synthetic benchmark — an excess of +15.05%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +11.10%, Health Care +8.12%, Residual Volatility +3.96%; the largest drags came from Historical Volatility -8.24%, Turnover -2.16%, Skewness -1.58%. Specific (stock-level) return contributed -12.42%.
  3. Risk attribution: Barra model volatility is 33.90% annualised; factor risk explains 52% of variance and specific risk 48%. The largest factor risk sources are Health Care 23.3%, Max Drawdown 17.2%, Historical Volatility 4.9%.
  4. Style tilt: size -0.59, momentum -0.41, volatility +0.64, liquidity -0.65; the weighted raw beta is 0.62. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+98.3 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +21.99%, selection +12.84% and interaction -21.01%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Prosight Management, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Prosight Management, LP reported 32 equity positions worth $515.48M in aggregate; its largest disclosed positions were LKFT ($59.25M), STTK ($52.16M), JANX ($50.86M).

How large is Prosight Management, LP's portfolio?

Prosight Management, LP reported $515.48M of long equity holdings across 32 positions as of 2026-Q3. Top-10 holdings account for 70.6% of reported value.

What is Prosight Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/prosight-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →